fluorescein-5-isothiocyanate has been researched along with B-Cell Chronic Lymphocytic Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coupek, P; Doubek, M; Klabusay, M; Pevna, M; Stehlikova, O | 1 |
| Gottlieb, DJ; Sartor, MM | 1 |
| Andreef, M; Carson, D; Eksioglu-Demiralp, E; Garland, J; Kitada, S; Reed, JC | 1 |
| Joshi, SS; Pavletic, ZS; Wang, P | 1 |
| Abbasi, F; Gaigalas, AK; Marti, GE; Vogt, RF; Wang, L | 1 |
| Haanen, C; Kalsbeek-Batenburg, E; Reutelingsperger, CP; Richel, DJ; Schaafsma, MR; Vermes, I | 1 |
| Kasper, RC; LeBoit, PE; Nihal, M; Wood, GS | 1 |
7 other study(ies) available for fluorescein-5-isothiocyanate and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
Topics: Adult; Aged; Aged, 80 and over; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Calibration; CD52 Antigen; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fluorometry; Glycoproteins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm, Residual; Patient Selection; Remission Induction | 2014 |
A single tube 10-color flow cytometry assay optimizes detection of minimal residual disease in chronic lymphocytic leukemia.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Color; Cyclophosphamide; Disease-Free Survival; Female; Flow Cytometry; Fluorescein-5-isothiocyanate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Neoplasm, Residual; Rituximab | 2013 |
A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis.
Topics: Animals; Apoptosis; Caspase 8; Caspase 9; Caspases; Cattle; Cytochrome c Group; Electroporation; Enzyme Activation; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Granzymes; Humans; In Vitro Techniques; Jurkat Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Molecular Weight; Proteins; Serine Endopeptidases; Serum Albumin, Bovine; Tumor Cells, Cultured | 2003 |
Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
Topics: Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Caenorhabditis elegans Proteins; Cell Cycle; Cell Division; Cell Line, Tumor; Coloring Agents; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Down-Regulation; Fluorescein-5-isothiocyanate; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Oligonucleotides, Antisense; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Vidarabine | 2002 |
Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
Topics: Antigens, CD20; CD4 Antigens; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Phycoerythrin; Sensitivity and Specificity | 2006 |
Apoptosis and secondary necrosis of lymphocytes in culture.
Topics: Annexin A5; Apoptosis; B-Lymphocytes; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Immunomagnetic Separation; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Necrosis; T-Lymphocytes; Tumor Cells, Cultured | 1997 |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
Topics: Adult; Atrophy; Cutis Laxa; Cyclosporine; DNA; Elastic Tissue; Female; Fluorescein-5-isothiocyanate; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; In Situ Hybridization; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Polymerase Chain Reaction; RNA, Viral; Skin Neoplasms; Tacrolimus | 2001 |